Molina Healthcare — Feb 5, 2026 release

The adjusted earnings guidance is burdened by $2.50 per share related to the implementation of a new Medicaid contract and underperformance in the traditional Medicare Advantage Part D (“MAPD”) product, which the Company will exit for 2027. • New store embedded earnings are now over $11.00 per diluted share. -MORE- Molina Healthcare, Inc. Reports Fourth Quarter and Year-End 2025 Financial Results Page 2 February 5, 2026 “We remain confident in our durable and sustaining operating platform,” said Joseph Zubretsky, President and Chief Executive Officer. “We believe that the imbalance between rates and trend marks 2026 as a trough year for Medicaid industry margins. Even at this low point in the cycle, we continue to produce positive pretax margins in Medicaid. We remain optimistic about the future earnings trajectory of the enterprise which includes anticipated rate restoration and future embedded earnings.” Premium Revenue Premium revenue was approximately $43.1 billion for the full year 2025, an increase of 11% year over year. The higher premium revenue reflects recent acquisitions, rate increases, and organic growth. Net Income GAAP net income for the full year 2025 was $8.92 per diluted share, a decrease of 56% year over year. Adjusted net income for the full year 2025 was $11.03 per diluted share, a decrease of 51% year over year. The fourth quarter and full year 2025 results were burdened by approximately $2.00 per share of unfavorable retroactive premium adjustments attributable